These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1639082)

  • 21. Sulfotransferase-mediated DNA binding of N-hydroxyarylamines(amide) in liver cytosols from human and experimental animals.
    Abu-Zeid M; Yamazoe Y; Kato R
    Carcinogenesis; 1992 Aug; 13(8):1307-14. PubMed ID: 1499081
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatic cell loss and proliferation induced by N-2-fluorenylacetamide, diethylnitrosamine, and aflatoxin B1 in relation to hepatoma induction.
    Nishizumi M; Albert RE; Burns FJ; Bilger L
    Br J Cancer; 1977 Aug; 36(2):192-7. PubMed ID: 199226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ultrastructural and metabolic determinants of resistance to azo-dye susceptibility to nitrosamine carcinogenesis of the guinea-pig.
    Bryant GM; Sohal RS; Argus MF; Arcos JC
    Br J Cancer; 1977 Dec; 36(6):678-91. PubMed ID: 413561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The peroxisome proliferator nafenopin does not suppress hepatocyte apoptosis in guinea-pig liver in vivo nor in human hepatocytes in vitro.
    Hasmall SC; James NH; Soames AR; Roberts RA
    Arch Toxicol; 1998 Dec; 72(12):777-83. PubMed ID: 9950074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell proliferation in carcinogenesis.
    Cohen SM; Ellwein LB
    Science; 1990 Aug; 249(4972):1007-11. PubMed ID: 2204108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carcinogenicity of quinoline by drinking-water administration in rats and mice.
    Matsumoto M; Kano H; Suzuki M; Noguchi T; Umeda Y; Fukushima S
    J Toxicol Sci; 2018; 43(2):113-127. PubMed ID: 29479033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutagenicities of quinoline and its derivatives.
    Nagao M; Yahagi T; Seino Y; Sugimura T; Ito N
    Mutat Res; 1977 Mar; 42(3):335-42. PubMed ID: 323699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in levels of ADP-ribose polymers in rat liver during 2-acetylaminofluorene-induced hepatocarcinogenesis.
    Kiehlbauch CC; Kosanke SD; Ringer DP
    Carcinogenesis; 1993 Jul; 14(7):1435-40. PubMed ID: 8330362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relative sensitivity of 32P-postlabelling of DNA and the autoradiographic UDS assay in the liver of mice exposed to 2-acetylaminofluorene (2AAF).
    Ashby J; Lefevre PA; Shank T; Lewtas J; Gallagher JE
    Mutat Res; 1991 Jun; 252(3):259-68. PubMed ID: 2052006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergistic effects of trans-4-acetylaminostilbene and 2-acetylaminofluorene at the level of tumor initiation.
    Hammerl R; Kirchner T; Neumann HG
    Chem Biol Interact; 1994 Oct; 93(1):11-28. PubMed ID: 7915206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New nonpeptide angiotensin II receptor antagonists. 2. Synthesis, biological properties, and structure-activity relationships of 2-alkyl-4-(biphenylylmethoxy)quinoline derivatives.
    Bradbury RH; Allott CP; Dennis M; Fisher E; Major JS; Masek BB; Oldham AA; Pearce RJ; Rankine N; Revill JM
    J Med Chem; 1992 Oct; 35(22):4027-38. PubMed ID: 1433210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different inhibitory effects in the early and late phase of treatment with KAT-681, a liver-selective thyromimetic, on rat hepatocarcinogenesis induced by 2-acetylaminofluorene and partial hepatectomy after diethylnitrosamine initiation.
    Hayashi M; Tamura T; Kuroda J; Ohnota H; Shibata N; Akahane M; Kashida Y; Mitsumori K
    Toxicol Sci; 2005 Mar; 84(1):22-8. PubMed ID: 15564315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Species restriction of the mitogenicity induced by lanatoside C. Lymphocyte activation by digitalis glycosides is confined to cells from digitalis resistant species.
    Hammarström L; Smith CI
    Immunology; 1979 Jun; 37(2):389-96. PubMed ID: 157324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of non-peptide bradykinin B2 receptor agonist (FR 190997) and antagonist (FR 173657).
    Gobeil F; Montagne M; Inamura N; Regoli D
    Immunopharmacology; 1999 Sep; 43(2-3):179-85. PubMed ID: 10596851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Different hepatic vascular response to noradrenaline and histamine between guinea-pig and rat.
    Shibamoto T; Narushima M; Ling YQ; Shimo T; Tsuchida H; Kurata Y; Ogura T
    Acta Physiol Scand; 2004 Mar; 180(3):255-63. PubMed ID: 14962007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between DNA strand breaks and specific DNA adducts in murine hepatocytes following in vivo and in vitro exposure to N-hydroxy-2-acetylaminofluorene and N-acetoxy-2-acetylaminofluorene.
    Vu VT; Møller ME; Grantham PH; Wirth PJ; Thorgeirsson SS
    Carcinogenesis; 1985 Jan; 6(1):45-52. PubMed ID: 4038475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of precision-cut liver slices to evaluate species differences in 2-acetylaminofluorene-induced unscheduled DNA synthesis.
    Lake BG; Beamand JA; Wield PT; Price RJ
    Toxicol Appl Pharmacol; 1996 Jun; 138(2):231-41. PubMed ID: 8658524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathological and hepatic ultrastructural effects of a single dose of perfluoro-n-decanoic acid in the rat, hamster, mouse, and guinea pig.
    Van Rafelghem MJ; Mattie DR; Bruner RH; Andersen ME
    Fundam Appl Toxicol; 1987 Oct; 9(3):522-40. PubMed ID: 3692011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Different effects of the liver mitogens triiodo-thyronine and ciprofibrate on the development of rat hepatocellular carcinoma.
    Ledda-Columbano GM; Perra A; Concas D; Cossu C; Molotzu F; Sartori C; Shinozuka H; Columbano A
    Toxicol Pathol; 2003; 31(1):113-20. PubMed ID: 12597455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carcinogenic activity of quinoline on rat liver.
    Hirao K; Shinohara Y; Tsuda H; Fukushima S; Takahashi M
    Cancer Res; 1976 Feb; 36(2 Pt 1):329. PubMed ID: 177193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.